Consecución de objetivos farmacocinéticos/farmacodinámicos en pacientes críticos con monitorización terapéutica de linezolid

Read full text Summarise with VIRAT
Authors: Irati Irigoyen Rodríguez, Leire Leache, Julen Fernández-González, Amaia Egües, Julián Librero
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Standard dosing of linezolid regimen frequently results in suboptimal exposure in critically ill patients. This study aimed to analyze the association between dosing regimens (total daily dose and infusion duration) and the probability of achieving pharmacokinetic/pharmacodynamic targets, as well as their microbiological and clinical impact. METHODS: A retrospective observational study was conducted in critically ill patients admitted to intensive care units who underwent therapeutic drug monitoring of linezolid between May 2021 and December 2023. Achievement of pharmacokinetic/pharmacodynamic targets (Cmin: 2-7 mg/L, AUC: 0-24/MIC: 80-120 mg*h/L, and T>MIC =85%) was evaluated according to the initial regimens (1,200 or 1,800 mg/day) and infusion duration (1 or 3 hours). Risk subgroups included obesity, augmented creatinine clearance, renal replacement therapy, and age

Fields of Study & Subjects

Antibiotics Pharmacokinetics and Efficacy Sepsis Diagnosis and Treatment Neutropenia and Cancer Infections

Publication details

Journal / source
Anales del Sistema Sanitario de Navarra
Volume
49
Issue
1
Pages
e1151–e1151
Publication date
31 March 2026
Language
ES